Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com

StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the stock.

A number of other research firms have also recently issued reports on EKSO. Lake Street Capital lowered their target price on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. HC Wainwright reissued a “buy” rating and issued a $9.00 price objective on shares of Ekso Bionics in a research report on Tuesday, January 14th.

Ekso Bionics Stock Down 3.5 %

Shares of NASDAQ EKSO opened at $0.51 on Friday. The firm’s 50-day moving average is $0.62 and its 200-day moving average is $0.84. The firm has a market capitalization of $11.31 million, a PE ratio of -0.79 and a beta of 1.46. Ekso Bionics has a 1 year low of $0.47 and a 1 year high of $2.16. The company has a current ratio of 2.81, a quick ratio of 2.14 and a debt-to-equity ratio of 0.28.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.